IRCT20230926059519N1招募中3 期
Investigating the effect of the combination of hydroalcoholic extracts of Tribulus terrestris, Platanus leaves and Medicago sativa on increasing production of platelets and other blood products in patients with thrombocytopenia: A Randomized Double-Blind Clinical Trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Definitive diagnosis of the patient
- •Age between 18 and 75 years
- •Platelet count test below 150 thousand
- •No spontaneous bleeding
- •No pregnancy
- •Completing the informed consent form
排除标准
- •- Reduction of platelets below 10,000 and the need for hospitalization
- •Active bleeding
研究者
相似试验
尚未招募
不适用
The effect of Saffron petal hydrogel on the prevention of radiotherapy-induced dermatitisRadiotherapy-induced mucositis is breast-conserving cancer patients.Acute radiodermatitis, Localized skin eruption due to drugs and medicamentL58.0, L27IRCT20180103038199N7Mashhad University of Medical Sciences80
招募中
3 期
Investigating the effect of a supplement of hydroalcoholic extract of Eryngium on the metabolic marker in type 2 diabetic patientsIRCT20181006041252N7Sabzevar University of Medical Sciences84
尚未招募
3 期
The effect of the combination of dimenhydrinate with metoclopramide and dimenhydrinate with ondansetron with dimenhydrinate alone in the prevention of nausea and vomiting after the surgeryCataract surgery.Cataract extraction statusZ98.4IRCT20200825048515N9Esfahan University of Medical Sciences160
已完成
3 期
Effect of Soybean on AlzheimerAlzheimer's disease.Other degenerative diseases of the nervous systemG30-G32IRCT20170702034861N9Kerman University of Medical Sciences50
进行中（未招募）
不适用
A RANDOMISED, DOUBLE-BLIND, ADD-ON STUDY OF HYDROCHLOROTHIAZIDE IN SUBJECTS WITH MODERATE TO SEVERE HYPERTENSION NOT ACHIEVING TARGET BLOOD PRESSURE ON OLMESARTAN MEDOXOMIL/AMLODIPINE FIXED DOSE COMBINATION 40/10 MG ALONEEssential hypertensionMedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionEUCTR2008-003535-20-DEDAIICHI SANKYO EUROPE GmbH1,965